News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics
Nova Mentis Life Science
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing
Filament Health
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
Cybin Inc.
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method
ATAI Life Sciences
Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers
Pharmadrug Inc.
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw
Entheon Biomedical
Braxia Scientific CEO, Chief Medical Officer Awarded $918,000 by Canadian Government to Study Benefits of Integrating Ketamine with Cognitive Behavioural Therapy to Reduce Suicidality
Braxia Scientific Corp.
Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application
Wellbeing Digital Sciences
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
NeonMind Biosciences Inc.
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT
Mind Medicine (MindMed)
Origin Therapeutics Launches To Fund Emerging Psychedelics Companies
Origin Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.